Drug Profile
Research programme: small-molecule therapeutics - EcoBiotics
Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator EcoBiotics
- Class Small molecules
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Infections; Inflammation
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Infections in Australia
- 28 Aug 2020 No recent reports of development identified for research development in Inflammation in Australia
- 07 Jul 2016 Early research in Infections in Australia (unspecified route)